Install
Zacks Small Cap Research coverage specifically looks to focus on small and micro-cap companies that are under followed or under valued by Wall Street.
- 38articles · 30d
- 3+ day agolatest article
- Aug 17, 2026earliest in window
- 0%with images
- 298avg words
- Economy, Business & Finance 33
- Finance & Business 25
- News 21
- Health & Wellness 10
- Medical 8
- Business & Industrial 6
- Industrial 5
- Health 4
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
BDMD: Baird Medical Reports Strong Revenue Growth for the 6-Month Period Ending 6/30/26
4+ day, 39+ min ago (274+ words) By Tom Kerr, CFA READ THE FULL BDMD RESEARCH REPORT On September 3, 2026, Baird Medical (NASDAQ: BDMD) released financial results for the 6-month period ending June 30, 2026, which showed strong revenue growth from non-China regions. Cash level profitability also improved significantly. EBITDA…...
CPKF Posts Another Strong Quarter with Diluted EPS Up 75% Year over Year
5+ day, 59+ min ago (278+ words) By Ann Heffron, CFA, CPA READ THE FULL CPKF RESEARCH REPORT Chesapeake Financial (OTCQX: CPKF) produced another strong quarter with 2026 second quarter net earnings surging $2.3 million, or 74%, to $5.5 million year over year, while 2026’s second quarter diluted EPS rose $0.50, or…...
UHAL: U-Haul Reported 1Q FY2027 Financial Results
6+ day, 26+ min ago (334+ words) By Steven Ralston, CFA READ THE FULL UHAL RESEARCH REPORT On August 20, 2026, U-Haul held its 20th Annual Virtual Analyst and Investor Meeting, which was largely composed of answering analyst and investor questions. Highlights from the 20th Annual Virtual Analyst & Investor Meeting Toy…...
BENF: Beneficient Releases 1st Fiscal Quarter Results (Period Ending 6/30/26)
1+ week, 4+ day ago (376+ words) By Tom Kerr, CFA READ THE FULL BENF RESEARCH REPORT 1st Quarter 2027 Results (period ending June 30, 2026) On August 14, 2026, Beneficient (NASDAQ: BENF) announced fiscal 1st quarter results for the period ending 6/30/26. Beneficient reported $212.5 million of investments at fair value as of June 30, 2026, up…...
TNXP: $11.0 Million in Tonmya® Net Revenue in 2Q26
1+ week, 4+ day ago (233+ words) READ THE FULL TNXP RESEARCH REPORT $11.0 Million in Net Revenue for Tonmya® in 2Q26 Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) is continuing the commercial launch of Tonmya® following its approval in August 2025 and commercial launch in November 2025. Sales metrics for the…...
HURA: Milestone Progression Over Next 12 Months
2+ week, 5+ day ago (71+ words) READ THE FULL HURA RESEARCH REPORT TuHURA generated no revenues in 2Q:26 and expended $8.8 million on operational activities related to advancing IFx-2.0, TBS-2025, and other programs, producing a net loss of $9.2 million or $0.14 per share. For the quarter ending June 30th, 2026, and…...
CING: Second Quarter Results
3+ week, 4+ day ago (305+ words) READ THE FULL CING RESEARCH REPORT Cingulate, Inc. (NASDAQ: CING) reported second quarter 2026 results on August 13th, 2026. During the three-month period, the company generated no revenue and recorded operating expense of $5.4 million. Since the end of the first quarter, cash balances…...
AEMD: Oncology Study Advances; Cost-Efficient Preclinical Activities Regarding Other Diseases Continue
3+ week, 4+ day ago (212+ words) READ THE FULL AEMD RESEARCH REPORT Early observations from 1st two cohorts showed consistent improvements in immune function Aethlon Medical (NASDAQ: AEMD), a clinical-stage medical therapeutic company advancing its lead asset, the Hemopurifier, to treat cancer and life-threatening viral infections, reported…...
COSM Produces Stellar Quarter
3+ week, 4+ day ago (783+ words) READ THE FULL COSM RESEARCH REPORT Record Q2 Results Demonstrate Accelerating Scale We see this as an important milestone because Cosmos generated only $65.3 million of revenue during all of 2025. The current run rate suggests to us that the company's growth trajectory…...
SWP.TO: Believe Share Repurchase Plan Underscores Company’s Confidence in its Outlook as Industry Fundamentals Appear to Improve
3+ week, 5+ day ago (119+ words) OTC: SWSSF | TSX: SWP.TO READ THE FULL SWP.TO RESEARCH REPORT Pick up in customer orders contributes to 17% y/y increase in processed volumes in 2Q26 Swiss Water Decaffeinated Coffee Inc. (OTC: SWSSF, TSX: SWP.TO) reported 2Q26 results that we…...